E. Roy Berger, MD, FACP, is a medical oncologist with over 30 years of experience in the diagnosis & treatment of prostate cancer and G-U malignancies & their supportive care.
He has extensive clinical experience as a principal investigator in pivotal trials, including those leading to the FDA approval of Provenge, strontium, & flutamide.
He is widely published, with > 150 articles, clinical communications, reviews, editorials & written 3 books. His book “Updated Guidelines for Surviving Prostate Cancer” sold over 50,000 copies.
He is a member of ASCO,SUO and on the Medical Advisory Board to Us Too International. He serves on the editorial board of Oncology Net Guide , has been the Physician Editor of Oncology & Biotech News as well as Contemporary Oncology.